Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
BMED
133
HOLDINGS
21%
ALSO IN BBP
BBP
57
HOLDINGS
36%
ALSO IN BMED
SECTOR DRIFT (BMED minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
RHYTHM PHARMACEUTICALS, INC. | 2.2% | 3.0% | 2.2% |
|
GILEAD SCIENCES INC | 3.6% | 2.1% | 2.1% |
|
NEUROCRINE BIOSCIENCES INC | 2.0% | 1.9% | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.8% | 3.0% | 1.8% |
|
BEIGENE LTD. SPONSORED ADR | 1.8% | 2.9% | 1.8% |
BMED Overweight Relative to BBP
|
BOSTON SCIENTIFIC CORP | 5.3% |
|
INTUITIVE SURGICAL INC | 4.4% |
 |
ARGENX SE ADR | 4.2% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 3.1% |
|
UCB SA | 2.6% |
|
ABBOTT LABORATORIES | 2.6% |
 |
MEDTRONIC PLC | 2.3% |
|
INSULET CORP | 2.3% |
BMED Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |
|
ACADIA PHARMACEUTICALS INC | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.4% |
 |
THERAVANCE BIOPHARMA INC | -2.3% |
|
BRIDGEBIO PHARMA, INC. | -2.2% |
|
LEXICON PHARMACEUTICALS, INC. | -2.2% |